Posts by: Magdalena Kegel

Magdalena Kegel

Magdalena is a writer with a passion for bridging the gap between the people performing research, and those who want or need to understand it. She writes about medical science and drug discovery. She holds an MS in Pharmaceutical Bioscience and a PhD — spanning the fields of psychiatry, immunology, and neuropharmacology — from Karolinska Institutet in Sweden.

February 8, 2016February 8, 2016

BPH Combo Tamsulosin-Dutasteride Treatment Superior to Monotherapy, Review Finds

News

Combination treatment with tamsulosin and dutasteride was superior to monotherapy with either compound in reducing benign prostatic hyperplasia (BPH) symptoms as well as the risk for disease progression. The combination is also most beneficial ... Read more

February 5, 2016February 5, 2016

Urologix Announces Sale of Its Assets to Private Buyer Following Debt Default

News

Urologix, Inc., recently announced the surrender of almost all of the company’s operating assets — including the Urologix name — to a secured creditor. The assets were, in turn, acquired by a private ... Read more

February 1, 2016February 1, 2016

British Health Institute Prepared to Support Laser System for BPH

News

The British National Institute for Health and Care Excellence (NICE) announced plans to support the use of GreenLight XPS 180 W laser system for the treatment of non-high-risk benign prostatic hyperplasia (BPH). But before ... Read more

January 28, 2016January 28, 2016

BPH Patients’ Quality of Life Improves Regardless of Treatment, Study Says

News

A Spanish multicenter study revealed that improvement in symptoms and quality of life of benign prostatic hyperplasia (BPH) patients in a real-life setting was equal across all investigated treatments, except for patients ... Read more

January 27, 2016January 27, 2016

Prostate Disease Could Be Set in Motion by Testosterone Exposure Before Birth

News

Researchers from the State University of Campinas, Brazil, report that the foundation for prostatic disease might be laid as early as during fetal development through exposure to altered levels of testosterone. Scientists first ... Read more

January 26, 2016January 26, 2016

BPH Patients Increasingly Likely to Postpone Surgery, Study Finds

News

A McGill University study reports on the changing characteristics of patients with benign prostatic hyperplasia (BPH) over 16 years — finding that the patient population is older and sicker. The ... Read more

January 25, 2016January 25, 2016

Botox’s Effectiveness as BPH Treatment Is Questioned

News

A review found that botulinum toxin did not appear to be an effective means to treat lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH). Christopher J. Chermansky and Michael B. ... Read more

January 22, 2016January 22, 2016

Prostate Cancer and BPH More Accurately Identified With PET Imaging Method

News

Thomas Jefferson University researchers say their method of using positron emission tomography (PET) to image the prostate appears to be much better at identifying both prostate cancer and benign prostatic hyperplasia ... Read more

January 13, 2016January 13, 2016

New Prostate Cancer Detection Test Supported by Leading Surgeon

News

Dr. David Samadi, a recognized expert in robotic prostate cancer surgery who runs the David Samadi Prostate Cancer Center in New York, has announced that he supports the use of the diagnostic test ConfirmMDx as ... Read more

January 8, 2016January 8, 2016

BPH Study of 2 TURP Surgical Methods Finds Advantages in B-TURP

News

A recent study has shown that bipolar transurethral resection of the prostate, or b-TURP, is superior to monopolar TURP (m-TURP) in terms catheterization time and hemoglobin decrease. In terms of other postoperative clinical ... Read more